| pubmed-article:15661263 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15661263 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15661263 | lifeskim:mentions | umls-concept:C0023473 | lld:lifeskim |
| pubmed-article:15661263 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:15661263 | lifeskim:mentions | umls-concept:C1334078 | lld:lifeskim |
| pubmed-article:15661263 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:15661263 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:15661263 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:15661263 | pubmed:dateCreated | 2005-1-21 | lld:pubmed |
| pubmed-article:15661263 | pubmed:abstractText | We investigated the peripheral blood gene expression profile of interferon induced transmembrane protein 1 (IFITM1) in sixty chronic myeloid leukemia (CML) patients classified according to new prognostic score (NPS). IFITM1 is a component of a multimeric complex involved in the trunsduction of antiproliferative and cell adhesion signals. Expression level of IFITM1 was found significantly different between the high- and low-risk groups (P = 9.7976 x 10(-11)) by real-time reverse transcription polymerase chain reaction (RT-PCR). Higher IFITM1 expression correlated with improved survival (P = 0.01). These results indicate that IFITM1 expression profiling could be used for molecular classification of CML, which may also predict survival. | lld:pubmed |
| pubmed-article:15661263 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15661263 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15661263 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15661263 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15661263 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15661263 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15661263 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15661263 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15661263 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:15661263 | pubmed:issn | 0145-2126 | lld:pubmed |
| pubmed-article:15661263 | pubmed:author | pubmed-author:WilliamsBryan... | lld:pubmed |
| pubmed-article:15661263 | pubmed:author | pubmed-author:IlhanOsmanO | lld:pubmed |
| pubmed-article:15661263 | pubmed:author | pubmed-author:BeksacMeralM | lld:pubmed |
| pubmed-article:15661263 | pubmed:author | pubmed-author:OzçelikTayfun... | lld:pubmed |
| pubmed-article:15661263 | pubmed:author | pubmed-author:OzcanMuhitM | lld:pubmed |
| pubmed-article:15661263 | pubmed:author | pubmed-author:OzbekU?urU | lld:pubmed |
| pubmed-article:15661263 | pubmed:author | pubmed-author:GürmanGünhanG | lld:pubmed |
| pubmed-article:15661263 | pubmed:author | pubmed-author:DalvaKlaraK | lld:pubmed |
| pubmed-article:15661263 | pubmed:author | pubmed-author:AkanHamdiH | lld:pubmed |
| pubmed-article:15661263 | pubmed:author | pubmed-author:FrevelMathias... | lld:pubmed |
| pubmed-article:15661263 | pubmed:author | pubmed-author:AkyerliCemali... | lld:pubmed |
| pubmed-article:15661263 | pubmed:author | pubmed-author:HolkoMichelle... | lld:pubmed |
| pubmed-article:15661263 | pubmed:author | pubmed-author:OzetGülsümG | lld:pubmed |
| pubmed-article:15661263 | pubmed:author | pubmed-author:SoydanEnderE | lld:pubmed |
| pubmed-article:15661263 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15661263 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:15661263 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15661263 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15661263 | pubmed:pagination | 283-6 | lld:pubmed |
| pubmed-article:15661263 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:15661263 | pubmed:meshHeading | pubmed-meshheading:15661263... | lld:pubmed |
| pubmed-article:15661263 | pubmed:meshHeading | pubmed-meshheading:15661263... | lld:pubmed |
| pubmed-article:15661263 | pubmed:meshHeading | pubmed-meshheading:15661263... | lld:pubmed |
| pubmed-article:15661263 | pubmed:meshHeading | pubmed-meshheading:15661263... | lld:pubmed |
| pubmed-article:15661263 | pubmed:meshHeading | pubmed-meshheading:15661263... | lld:pubmed |
| pubmed-article:15661263 | pubmed:meshHeading | pubmed-meshheading:15661263... | lld:pubmed |
| pubmed-article:15661263 | pubmed:meshHeading | pubmed-meshheading:15661263... | lld:pubmed |
| pubmed-article:15661263 | pubmed:meshHeading | pubmed-meshheading:15661263... | lld:pubmed |
| pubmed-article:15661263 | pubmed:meshHeading | pubmed-meshheading:15661263... | lld:pubmed |
| pubmed-article:15661263 | pubmed:meshHeading | pubmed-meshheading:15661263... | lld:pubmed |
| pubmed-article:15661263 | pubmed:meshHeading | pubmed-meshheading:15661263... | lld:pubmed |
| pubmed-article:15661263 | pubmed:meshHeading | pubmed-meshheading:15661263... | lld:pubmed |
| pubmed-article:15661263 | pubmed:meshHeading | pubmed-meshheading:15661263... | lld:pubmed |
| pubmed-article:15661263 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15661263 | pubmed:articleTitle | Expression of IFITM1 in chronic myeloid leukemia patients. | lld:pubmed |
| pubmed-article:15661263 | pubmed:affiliation | Department of Molecular Biology and Genetics, Bilkent University, Bilkent, 06800 Ankara, Turkey. | lld:pubmed |
| pubmed-article:15661263 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15661263 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:8519 | entrezgene:pubmed | pubmed-article:15661263 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:15661263 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15661263 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15661263 | lld:pubmed |
